Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

CLOVER BIO-B

2.550
-0.040-1.54%
Volume:3.97M
Turnover:10.00M
Market Cap:3.31B
PE:-3.20
High:2.590
Open:2.550
Low:2.480
Close:2.590
52wk High:3.180
52wk Low:0.185
Shares:1.30B
HK Float Shares:1.30B
Volume Ratio:1.49
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.796
ROE:-648.53%
ROA:-47.64%
PB:-1.76
PE(LYR):-3.20
PS:57.86

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
CLOVER BIO-B
Exchange:
SEHK
Establishment Date:
2007
Employees:
243
Office Location:
No. 758 West Nanjing Road,Room 1901,Jing'an District,Shanghai,China
Website:
http://www.cloverbiopharma.com
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Clover Biopharmaceuticals Ltd is an investment holding company primarily engaged in the research and development, manufacture and commercialization of innovative vaccines. The Company’s products and candidates include Respiratory Syncytial Virus (RSV) Vaccine (SCB-1019), seasonal quadrivalent influenza vaccine AdimFlu-S, SCB-219M, COVID-19 Vaccine and others. The Company leverages the Trimer-Tag technology platform to conduct research and development (R&D) for innovative vaccines that can fulfill unmet need, with a focus on building a respiratory vaccine franchise and establishing a presence in the pediatric vaccine market. The Trimer-Tag is a product development platform for the creation of protein-based vaccines based on naturally trimerization-dependent targets. The Company conducts its business in the domestic and overseas markets.

Directors

Name
Position
LIANG Peng
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
Liang Joshua G
Executive Director
Xiaobin Wu
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
LIAO Xiang
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
Jeffrey Farrow
Independent Director,Audit Committee Member
Thomas LEGGETT
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
Xiaodong Wang
Director,Member of the Remuneration and Assessment Committee
Donna Marie Ambrosino
Director,Member of the Nomination Committee

Shareholders

Name
Position
Liang Joshua G
CEO
ZHOU Qing Ling
Corporate Secretary
WANG Xiao Yan
Corporate Secretary
LIANG Peng
Chief Science Officer
NI Qi Rui
Other Senior Executives
CAI Long He
Other Senior Executives